During the past decade, Latin Clinical Trial Center conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 13 clinical trials were completed, i.e. on average, 39.4% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 11 clinical trials were completed. i.e. 42.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Latin Clinical Trial Center" #1 sponsor was "Eli Lilly and Company" with 24 trials, followed by "Enanta Pharmaceuticals, Inc" with 2 trials sponsored, "ImmuPharma" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Fidia Farmaceutici s.p.a." with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Latin Clinical Trial Center" #1 collaborator was "ICON Clinical Research" with 1 trials as a collaborator, "Incyte Corporation" with 1 trials as a collaborator, "Nektar Therapeutics" with 1 trials as a collaborator, "Novo Nordisk A/S" with 1 trials as a collaborator and "Triangle Biostatistics" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Latin Clinical Trial Center" are "Diabetic Peripheral Neuropathic Pain" (4 trials), "Rheumatoid Arthritis" (4 trials), "Chronic Low-back Pain" (3 trials), "Obesity" (3 trials) and "Osteoarthritis" (3 trials). Many other conditions were trialed in "Latin Clinical Trial Center" in a lesser frequency.

Most popular intervention types in "Latin Clinical Trial Center" are "Drug" (33 trials), "Other" (3 trials), "Procedure" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (29 trials), "LY3016859" (3 trials), "LY3556050" (3 trials), "Tirzepatide" (3 trials) and "Baricitinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Latin Clinical Trial Center" are 35 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Latin Clinical Trial Center". undefined are not yet recruiting, 6 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Latin Clinical Trial Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Latin Clinical Trial Center, 0 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".